La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Elevance Health Résultats passés
Passé contrôle des critères 3/6
Elevance Health a connu une croissance annuelle moyenne de ses bénéfices de 8%, tandis que le secteur Healthcare a vu ses bénéfices augmenter de en hausse à 7.1% par an. Les revenus ont augmenté de en hausse à un taux moyen de 11.9% par an. Le rendement des capitaux propres de Elevance Health est 15.8% et ses marges nettes sont de 3.9%.
Informations clés
8.0%
Taux de croissance des bénéfices
9.9%
Taux de croissance du BPA
Healthcare Croissance de l'industrie | 8.5% |
Taux de croissance des recettes | 11.9% |
Rendement des fonds propres | 15.8% |
Marge nette | 3.9% |
Dernière mise à jour des bénéfices | 30 Jun 2024 |
Mises à jour récentes des performances passées
Recent updates
Here's Why We Think Elevance Health (NYSE:ELV) Is Well Worth Watching
Aug 02Elevance Health: Healthcare Services Segment Is Gaining Traction
Jul 31Elevance Health: Buy A Dividend Growth Machine
Jul 18Elevance Health: Favorable Trends Are Emerging (Rating Upgrade)
Jun 28Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?
Jun 11Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher
May 27We Think Shareholders Will Probably Be Generous With Elevance Health, Inc.'s (NYSE:ELV) CEO Compensation
May 09Elevance Health (NYSE:ELV) Has Announced A Dividend Of $1.63
Apr 25Elevance Health: It's Not Too Late To Buy Their Dividend Growth
Apr 23Is Elevance Health (NYSE:ELV) Using Too Much Debt?
Apr 16Elevance Health: Not Doing Enough In 2024 To Justify Premium Price
Apr 11Elevance Health, Inc.'s (NYSE:ELV) Earnings Haven't Escaped The Attention Of Investors
Apr 01Elevance: A Healthy Dose Of Dividend Growth
Mar 21Elevance Heath: Financial Growth And Technical Strength Indicate A Buy
Mar 07Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63
Feb 19Elevance Health: Time To Buy This Incredible Dividend Growth Stock
Jan 26Slowing Rates Of Return At Elevance Health (NYSE:ELV) Leave Little Room For Excitement
Jan 19Is Elevance Health (NYSE:ELV) A Risky Investment?
Jan 02Elevance Health, Inc.'s (NYSE:ELV) Shares Not Telling The Full Story
Dec 18A Look At Elevance's Margin Dynamics
Nov 23Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?
Nov 16Elevance Health: A High Conviction Defensive Blue Chip Buy
Oct 19These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely
Oct 04Elevance: Pave The Way For The Next UnitedHealth
Sep 21Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital
Sep 18Here's The Price I Would Buy Elevance Health Stock
Sep 13If EPS Growth Is Important To You, Elevance Health (NYSE:ELV) Presents An Opportunity
Aug 18Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?
Aug 04Narrowing Down High-Quality Dividend Growth: Elevance Health Is Elemental
Jul 24Elevance Health: Beaten Down Share Price Offers Solid Potential
Jul 10Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly
Jul 05Elevance Health: A Critical Update (Rating Downgrade)
Jun 05Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher
Jun 04Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?
May 05We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt
Apr 04Elevance Health's (NYSE:ELV) Dividend Will Be Increased To $1.48
Feb 17Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital
Feb 13Elevance Health: Attractive On Its Expansion Catalysts
Feb 09Elevance Health (NYSE:ELV) Has Announced That It Will Be Increasing Its Dividend To $1.48
Jan 28Elevance Health acquiring Blue Cross and Blue Shield of Louisiana
Jan 23Elevance Health Offers Great Value
Jan 17At US$483, Is Elevance Health Inc. (NYSE:ELV) Worth Looking At Closely?
Jan 17Elevance Health: Strong And Steady EPS Growth Ahead, High Relative Strength Name
Jan 02Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly
Nov 28Does Elevance Health (NYSE:ELV) Deserve A Spot On Your Watchlist?
Nov 16Elevance Health to acquire speciality pharmacy from CarepathRx
Nov 09Ventilation des recettes et des dépenses
Comment Elevance Health gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
---|---|---|---|---|
30 Jun 24 | 171,719 | 6,691 | 37,407 | 0 |
31 Mar 24 | 171,745 | 6,244 | 36,666 | 0 |
31 Dec 23 | 171,340 | 5,987 | 36,236 | 0 |
30 Sep 23 | 168,626 | 6,127 | 35,704 | 0 |
30 Jun 23 | 165,716 | 6,310 | 33,553 | 0 |
31 Mar 23 | 160,676 | 6,094 | 31,749 | 0 |
31 Dec 22 | 156,599 | 5,894 | 30,696 | 0 |
30 Sep 22 | 153,251 | 6,166 | 29,605 | 0 |
30 Jun 22 | 149,134 | 6,072 | 28,496 | 0 |
31 Mar 22 | 144,353 | 6,228 | 27,590 | 0 |
31 Dec 21 | 138,643 | 6,158 | 26,604 | 0 |
30 Sep 21 | 133,883 | 5,518 | 26,357 | 0 |
30 Jun 21 | 129,219 | 4,231 | 25,839 | 0 |
31 Mar 21 | 124,632 | 4,714 | 25,675 | 0 |
31 Dec 20 | 121,868 | 4,572 | 25,202 | 0 |
30 Sep 20 | 117,449 | 4,955 | 23,013 | 0 |
30 Jun 20 | 112,965 | 5,916 | 20,850 | 0 |
31 Mar 20 | 109,167 | 4,779 | 17,955 | 0 |
31 Dec 19 | 104,212 | 4,807 | 15,356 | 0 |
30 Sep 19 | 100,165 | 4,298 | 14,323 | 0 |
30 Jun 19 | 96,742 | 4,074 | 13,706 | 0 |
31 Mar 19 | 94,220 | 3,989 | 13,758 | 0 |
31 Dec 18 | 92,091 | 3,750 | 14,020 | 0 |
30 Sep 18 | 91,409 | 4,556 | 13,681 | 0 |
30 Jun 18 | 90,584 | 4,344 | 13,146 | 0 |
31 Mar 18 | 90,061 | 4,145 | 12,772 | 0 |
31 Dec 17 | 90,049 | 3,843 | 12,650 | 0 |
30 Sep 17 | 89,055 | 2,980 | 12,520 | 0 |
30 Jun 17 | 88,038 | 2,851 | 12,634 | 0 |
31 Mar 17 | 87,083 | 2,777 | 12,549 | 0 |
31 Dec 16 | 84,862 | 2,470 | 12,559 | 0 |
30 Sep 16 | 83,364 | 2,282 | 12,562 | 0 |
30 Jun 16 | 81,866 | 2,319 | 12,518 | 0 |
31 Mar 16 | 80,412 | 2,398 | 12,590 | 0 |
31 Dec 15 | 79,158 | 2,560 | 12,535 | 0 |
30 Sep 15 | 77,959 | 2,886 | 12,299 | 0 |
30 Jun 15 | 76,605 | 2,862 | 12,187 | 0 |
31 Mar 15 | 75,066 | 2,734 | 12,032 | 0 |
31 Dec 14 | 73,886 | 2,560 | 11,748 | 0 |
30 Sep 14 | 72,792 | 2,362 | 11,361 | 0 |
30 Jun 14 | 72,090 | 2,385 | 10,936 | 0 |
31 Mar 14 | 71,307 | 2,453 | 10,485 | 0 |
31 Dec 13 | 71,024 | 2,634 | 9,953 | 0 |
30 Sep 13 | 68,443 | 2,785 | 9,487 | 0 |
Des revenus de qualité: ELV a des bénéfices de haute qualité.
Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de ELV (3.9%) sont supérieures à celles de l'année dernière (3.8%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: Les bénéfices de ELV ont augmenté de 8% par an au cours des 5 dernières années.
Accélération de la croissance: La croissance des bénéfices de ELV au cours de l'année écoulée ( 6% ) est inférieure à sa moyenne sur 5 ans ( 8% par an).
Bénéfices par rapport au secteur d'activité: La croissance des bénéfices ELV au cours de l'année écoulée ( 6% ) n'a pas surpassé celle du secteur Healthcare 6%.
Rendement des fonds propres
ROE élevé: Le retour sur capitaux propres de ELV ( 15.8% ) est considéré comme faible.